Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

Lestaurtinib

EU orphan designation number: EU/3/06/389   
Active ingredient: Lestaurtinib
Indication: Treatment of acute myeloid leukaemia
Sponsor: Cephalon Europe
5 rue Charles Martigny, F-94700 Maisons-Alfort CEDEX, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2006 Centralised Orphan - Designation EMEA/OD/020/06 (2006)3438 of 25/07/2006
25/05/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/020/06/T/01 (2007)2285 of 22/05/2007